| Primary |
| Product Used For Unknown Indication |
43.5% |
| Drug Use For Unknown Indication |
35.0% |
| Anxiety |
4.1% |
| Urticaria |
3.2% |
| Psoriasis |
2.4% |
| Pruritus |
2.1% |
| Hyperemesis Gravidarum |
1.8% |
| General Anaesthesia |
1.2% |
| Dermatitis Allergic |
0.9% |
| Suicide Attempt |
0.9% |
| Bipolar Disorder |
0.6% |
| Insomnia |
0.6% |
| Intentional Overdose |
0.6% |
| Mental Disorder |
0.6% |
| Muscle Relaxant Therapy |
0.6% |
| Poisoning |
0.6% |
| Prurigo |
0.6% |
| Affective Disorder |
0.3% |
| Agitation |
0.3% |
| Autoimmune Hepatitis |
0.3% |
|
| Respiratory Arrest |
24.2% |
| Poisoning |
16.8% |
| Completed Suicide |
10.5% |
| Poisoning Deliberate |
6.3% |
| Cardiac Arrest |
4.2% |
| Intentional Drug Misuse |
4.2% |
| Toxicity To Various Agents |
4.2% |
| Drug Ineffective |
3.2% |
| Mental Status Changes |
3.2% |
| Torsade De Pointes |
3.2% |
| Abnormal Behaviour |
2.1% |
| Acute Generalised Exanthematous Pustulosis |
2.1% |
| Death |
2.1% |
| Drug Abuse |
2.1% |
| Drug Toxicity |
2.1% |
| Psoriasis |
2.1% |
| Staphylococcal Infection |
2.1% |
| Urinary Retention |
2.1% |
| Vomiting |
2.1% |
| Agitation |
1.1% |
|
| Secondary |
| Product Used For Unknown Indication |
43.9% |
| Drug Use For Unknown Indication |
26.1% |
| Drug Abuse |
7.6% |
| Hyperemesis Gravidarum |
2.9% |
| Suicide Attempt |
2.8% |
| Foetal Exposure During Pregnancy |
2.3% |
| Ill-defined Disorder |
2.3% |
| Anxiety |
1.6% |
| Depression |
1.4% |
| Agitation |
1.2% |
| Urticaria |
1.1% |
| Completed Suicide |
1.1% |
| Opportunistic Infection Prophylaxis |
1.1% |
| Anaesthesia |
0.9% |
| Hypertension |
0.8% |
| Pruritus |
0.7% |
| Pain |
0.6% |
| Insomnia |
0.6% |
| Antiretroviral Therapy |
0.6% |
| Migraine |
0.5% |
|
| Completed Suicide |
28.9% |
| Toxicity To Various Agents |
16.5% |
| Respiratory Arrest |
9.4% |
| Poisoning |
7.6% |
| Death |
4.8% |
| Drug Toxicity |
4.2% |
| Drug Abuse |
3.4% |
| Cardio-respiratory Arrest |
3.2% |
| Urticaria |
3.0% |
| Cardiac Arrest |
2.6% |
| Ventricular Extrasystoles |
2.4% |
| Intentional Drug Misuse |
2.0% |
| Unresponsive To Stimuli |
2.0% |
| Overdose |
1.8% |
| Maternal Exposure During Pregnancy |
1.6% |
| Suicide Attempt |
1.6% |
| Vomiting |
1.6% |
| Rash Pruritic |
1.2% |
| Somnolence |
1.2% |
| Vision Blurred |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.9% |
| Drug Use For Unknown Indication |
25.6% |
| Pain |
4.9% |
| Depression |
4.7% |
| Hypertension |
4.3% |
| Anxiety |
4.2% |
| Prophylaxis |
3.1% |
| Pruritus |
2.9% |
| Asthma |
2.9% |
| Psoriasis |
2.4% |
| Hepatitis C |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Insomnia |
1.9% |
| Diabetes Mellitus |
1.6% |
| Bipolar Disorder |
1.6% |
| Hiv Infection |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Sleep Disorder |
1.6% |
| Nausea |
1.5% |
| Premedication |
1.5% |
|
| Vomiting |
13.8% |
| Weight Increased |
11.7% |
| Weight Decreased |
11.3% |
| Urticaria |
6.2% |
| Rash |
5.4% |
| Type 2 Diabetes Mellitus |
5.2% |
| Withdrawal Syndrome |
5.0% |
| Pain |
4.5% |
| Death |
4.3% |
| Tremor |
4.0% |
| Drug Ineffective |
3.8% |
| Urinary Tract Infection |
3.2% |
| Pneumonia |
3.1% |
| Pancreatitis |
2.8% |
| Vision Blurred |
2.7% |
| Dyspnoea |
2.6% |
| Oedema Peripheral |
2.6% |
| Pyrexia |
2.6% |
| Pruritus |
2.6% |
| Renal Failure |
2.6% |
|
| Interacting |
| Coccidioidomycosis |
27.6% |
| Product Used For Unknown Indication |
24.1% |
| Mental Disorder |
13.8% |
| Cardiovascular Disorder |
10.3% |
| Urticaria |
10.3% |
| Hypersensitivity |
6.9% |
| Ill-defined Disorder |
6.9% |
|
| Confusional State |
20.0% |
| Drug Interaction |
20.0% |
| Malaise |
20.0% |
| Nodal Rhythm |
20.0% |
| Ventricular Tachycardia |
20.0% |
|
